AGP Executive Report
Last update: 5 minutes agoAutoimmune After COVID: A new review of eight large studies (including Germany) links COVID-19 to a higher risk of developing new autoimmune diseases afterward, with adjusted risk increases reported across many body systems—though the absolute risk for any one condition stays low. Hidradenitis Breakthrough: German researchers report povorcitinib (a JAK1 inhibitor) rapidly improves moderate-to-severe hidradenitis suppurativa in two phase 3 trials, with about 40–42% reaching key response targets versus 30% on placebo. Emergency Care Pressure: A study ties emergency department overcrowding and “corridor care” to higher patient mortality, adding to calls for staffing and flow fixes. Forensic MRI for Legal Age: German researchers test a more detailed MRI staging approach for knee growth plates to estimate age in cases involving undocumented young people, showing it’s feasible but limited for key legal thresholds. Digital Health & Privacy: Reports highlight ongoing concerns about AI “agent” activity and leaked user images, underscoring privacy and oversight gaps. Workforce & Care Access: A major German pharma cold-store expansion (Movianto) points to growing logistics capacity for medicines.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.